IMIPRAMINE IN SCHIZOPHRENIA WITH DEPRESSIVE SYMPTOMATOLOGY1

Depressive mood is a common accompaniment of schizophrenia. The present study was taken up with the aim to study the effect of imipramine on depressivse symptoms of schizophrenia. Eighteen patients of schizophrenia with depressive symptoms were studied under a double blind controlled design with a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Dua, Dinesh, Agarwal, A.K., Dalal, P.K.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 1990
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990171/
https://www.ncbi.nlm.nih.gov/pubmed/21927462
_version_ 1782192443551121408
author Dua, Dinesh
Agarwal, A.K.
Dalal, P.K.
author_facet Dua, Dinesh
Agarwal, A.K.
Dalal, P.K.
author_sort Dua, Dinesh
collection PubMed
description Depressive mood is a common accompaniment of schizophrenia. The present study was taken up with the aim to study the effect of imipramine on depressivse symptoms of schizophrenia. Eighteen patients of schizophrenia with depressive symptoms were studied under a double blind controlled design with a chlorpromazine-imipramine and a chlorpromazine-placebo group. Both the groups showed significant improvement (p< .001) after the 6 week trial and the addition of imipramine to chlorpromazine therapy did not have any advantageous or deleterious effect.
format Text
id pubmed-2990171
institution National Center for Biotechnology Information
language English
publishDate 1990
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-29901712011-09-16 IMIPRAMINE IN SCHIZOPHRENIA WITH DEPRESSIVE SYMPTOMATOLOGY1 Dua, Dinesh Agarwal, A.K. Dalal, P.K. Indian J Psychiatry Original Article Depressive mood is a common accompaniment of schizophrenia. The present study was taken up with the aim to study the effect of imipramine on depressivse symptoms of schizophrenia. Eighteen patients of schizophrenia with depressive symptoms were studied under a double blind controlled design with a chlorpromazine-imipramine and a chlorpromazine-placebo group. Both the groups showed significant improvement (p< .001) after the 6 week trial and the addition of imipramine to chlorpromazine therapy did not have any advantageous or deleterious effect. Medknow Publications 1990 /pmc/articles/PMC2990171/ /pubmed/21927462 Text en Copyright: © Indian Journal of Psychiatry http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Dua, Dinesh
Agarwal, A.K.
Dalal, P.K.
IMIPRAMINE IN SCHIZOPHRENIA WITH DEPRESSIVE SYMPTOMATOLOGY1
title IMIPRAMINE IN SCHIZOPHRENIA WITH DEPRESSIVE SYMPTOMATOLOGY1
title_full IMIPRAMINE IN SCHIZOPHRENIA WITH DEPRESSIVE SYMPTOMATOLOGY1
title_fullStr IMIPRAMINE IN SCHIZOPHRENIA WITH DEPRESSIVE SYMPTOMATOLOGY1
title_full_unstemmed IMIPRAMINE IN SCHIZOPHRENIA WITH DEPRESSIVE SYMPTOMATOLOGY1
title_short IMIPRAMINE IN SCHIZOPHRENIA WITH DEPRESSIVE SYMPTOMATOLOGY1
title_sort imipramine in schizophrenia with depressive symptomatology1
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990171/
https://www.ncbi.nlm.nih.gov/pubmed/21927462
work_keys_str_mv AT duadinesh imipramineinschizophreniawithdepressivesymptomatology1
AT agarwalak imipramineinschizophreniawithdepressivesymptomatology1
AT dalalpk imipramineinschizophreniawithdepressivesymptomatology1

Ejemplares similares